Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Perspective Therapeutics (CATX) Net Margin (2016 - 2023)

Perspective Therapeutics' Net Margin history spans 14 years, with the latest figure at 105.73% for Q4 2023.

  • On a quarterly basis, Net Margin changed N/A to 105.73% in Q4 2023 year-over-year; TTM through Dec 2023 was 1476.84%, a N/A change, with the full-year FY2023 number at 631.31%, changed N/A from a year prior.
  • Net Margin hit 105.73% in Q4 2023 for Perspective Therapeutics, up from 35.88% in the prior quarter.
  • Over the last five years, Net Margin for CATX hit a ceiling of 105.73% in Q4 2023 and a floor of 236.92% in Q3 2022.
  • Historically, Net Margin has averaged 54.04% across 5 years, with a median of 46.29% in 2022.
  • Biggest five-year swings in Net Margin: plummeted -14944bps in 2022 and later skyrocketed 20104bps in 2023.
  • Tracing CATX's Net Margin over 5 years: stood at 40.75% in 2019, then grew by 10bps to 36.8% in 2020, then plummeted by -55bps to 56.96% in 2021, then tumbled by -316bps to 236.92% in 2022, then soared by 145bps to 105.73% in 2023.
  • Business Quant data shows Net Margin for CATX at 105.73% in Q4 2023, 35.88% in Q3 2023, and 108.0% in Q2 2023.